Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2023

Apr 5, 2023

30870_dirs_2023-04-05_2f7d595b-a23a-49b4-af40-f1db745eeccc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-04-03

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-03 Common Stock A 530 $37.71 Acquired 25420 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 83 Indirect

Footnotes

F1: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.